Table 1.

Patient data

ID	Age/gender	Infection timea	Pango lineage	Seq. interval	Comorbidities	Symptoms	Immunosuppressive medicationb	Complications	ICU	Ventilationc	Treatment (R/D/P)d	Outcome
P01	53 F	90	B.1.8	0–83 days	Follicular lymphoma (in remission)	Dyspnea, cough	Obinutuzumab (3 months prior to admission)	Pneumonia	No	–	R (d63-d72/d91-95), P (d95; d97, d99)	Discharged with no symptoms on day 138
P03	34 M	30	A	0–28 days	Diabetes, renal failure, adiposity	Cough, fever	–	–	No	LFOT	R (d9/d12)	Discharged with no symptoms on day 33
P05	61 M	65	B.1.36.1	0–65 days	Diabetes	Hypoxia with accompanying syncope	–	Severe ARDS, septic shock, acute renal failure	Yes	Invasive	D (continuously), Hydrocortisone (d4-12)	Discharged with no symptoms on day 87
P06	43 M	47	B.1.177.81	0–46 days	Pre-diabetes, adiposity	Dyspnea, cough	–	Severe ARDS, acute renal failure, septic shock	Yes	Invasive	D (d2-d18), Hydrocortisone	Transfer to rehabilitation center on day 35
P07	75 F	57	B.1.1	0–47 days	Renal failure, granulomatosis with polyangiitis, hypertension	Dyspnea, cough	Cyclophosphamide (1 month prior to admission)	Severe ARDS	Yes	LFOT/HFOT/invasive	D (d35-d41)	Discharged with atrial fibrillation and dyspnea on day 43
P08	50 F	38	B.1.1	0–24 days	Diabetes, adiposity, hypertension	Pyrexia, dyspnea, nausea, cephalalgia	–	Severe ARDS, acute renal failure, asystole with successful cardiopulmonary resuscitation	Yes	Invasive	D (before admission and d12-d16)	Discharged with Dyspnea and on day 41
P09	62 M	39	B.1.177.81	0–12 days	Diabetes, adiposity, hypertension	Pyrexia, dyspnea, fatigue	–	Severe ARDS, acute renal failure, pneumogenic sepsis	Yes	LFOT/HFOT/invasive	D (before admission and d1-d9)	Discharged with no symptoms on day 54
P10	75 M	55	A	0–24 days	COPD, adiposity, hypertension	Progressive pulmonary failure	–	Moderate ARDS, acute renal failure, sepsis, circulatory failure with successful cardiopulmonary resuscitation	Yes	Invasive	–	Discharged with no symptoms on day 56
P13	60 F	57	A	0–57 days	Rheumatoid arthritis	–	Methotrexate (weekly) Rituximab (most recent administration unknown)	Severe ARDS, acute renal failure, sepsis	Yes	LFOT/invasive	R (before admission and d9-15), D (before admission and d9 –d39)	Deceased 41 days after admission, septic shock with multi-organ failure
P14	59 M	57	B.1.1.277	0–29 days	Liver transplant recipient, hypertension	Dyspnea	Tacrolimus (on admission) Basiliximab (most recent administration unknown)	Pneumonia	Yes	LFOT/HFOT/invasive	D (d20 – d24)	Discharged with no symptoms on day 67
P15	70 F	63	AC.1	0–33 days	Diabetes, adiposity, hypertension	Dyspnea, cough	–	Severe ARDS, heparin induced thrombocytopenia	Yes	Invasive	D (d4 - d6)	Discharged with no symptoms on day 66
P16	75 M	26	B.1	0–25 days	COPD, hypertension	Pyrexia, dyspnea, fatigue, progressive pulmonary failure	–	ARDS, acute atrial fibrillation, acute renal failure, intrahepatic cholestasis	Yes	Invasive	Prednisolone	Discharged with no symptoms on day 92
P17	77 M	52	B.1.1	0–13 days	COPD, rheumatoid arthritis, hypertension, diabetes, renal failure	Dyspnea, pyrexia, diarrhea	Methotrexate (weekly)	Severe ARDS, acute renal failure, multiple septic episodes, critical illness polyneuropathy, and myopathy	Yes	LFOT/invasive	Prednisolone, Hydrocortisone continuously	Discharged with no respiratory symptoms on day 205
P18	66 F	146	A.9	0–117 days	Dementia, hypertension, adiposity, renal failure, Goodpasture syndrome	Dyspnea, altered vigilance	Single dose rituximab, cyclophosphamide (8–10 months prior to admission)	ARDS, AV block I°, sepsis, cardiac decompensation (NYHA IV)	Yes	HFOT/invasive	Hydrocortisone for 3days, Prednisolone continuously	Discharged with no symptoms on day 160

^aInterval between admission to the hospital and last qRT-PCR positive SARS-CoV-2 report in the respiratory tract.

^bImmunosuppressive medication upon admission.

^cLFOT: low-flow oxygen therapy; HFOT: high-flow oxygen therapy.

^dD: dexamethasone; R: remdesivir; P: convalescent plasma.